Dr. Matthew G. Mischel, MD

Dr. Mischel practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Mischel's NPI, 1013996172, was assigned on January 16, 2006. Dr. Mischel graduated from Tufts University School Of Medicine in 1984. Dr. Mischel's California license number on file is G57538.

Dr. Mischel's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Mischel's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Mischel is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Mischel to 4 more hospitals, 4 dialysis centers, 4 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mischel practices, 14 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mischel's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mischel is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mischel has a license on file in California.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, gout, hypercalcemia, kidney cysts and kidney disease among the conditions Dr. Mischel treats.

CMS data shows 8,373 Medicare services from Dr. Mischel across 41 procedure codes in 2024, for 755 Medicare patients. Medicare paid $369,013 for them.

CMS counts 755 Medicare patients who saw Dr. Mischel in 2024. The largest group is 75 to 84, with 293 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mischel's median patient age at 74, with 44% women.

In 2024, Dr. Mischel wrote 6,995 Medicare Part D claims for 640 patients. 88% of them were for generic drugs. CMS names the drug for 6,151 of them, across 119 drugs with 11 or more claims each, at $582,722 in total drug cost. In 2023, CMS named 5,746 claims across 123 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mischel for performance year 2024, reported as part of a group. Dr. Mischel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mischel as offering telehealth.

CMS Open Payments shows 165 general payments to Dr. Mischel from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Amgen Inc. paid the most, $1,134.

Dmand AI lists 1 award for Dr. Mischel, most recently CMS Stage 1 EHR in 2013.

Dr. Mischel graduated from Tufts University School Of Medicine in 1984.

Dr. Mischel is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.